Searched for
LUPIN DIGITAL HEALTH
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Hunt for R&D talent picks up pace at health-tech, pharma firmsPharmaceutical and health-tech companies are significantly expanding their research and development teams to foster innovation and meet str...
- Eye On Earnings: What to expect from United Spirits, Lupin, BHELMore than 500 companies are scheduled to release the earnings for the quarter and half-year ended September on Wednesday.
- Lupin Digital Health launches first-of-its-kind digital heart failure clinicThe digital clinic provides in-clinic consultation with at-home patient monitoring and care. A team of experts, including paramedics, nurse...
- Lupin looks to hire talent in digital health, diagnostics, data science"The pharma industry is very bullish on growth right now. We are focusing on ramping up for new-age roles like product development speciali...
- Lupin's foray into diagnostics appears a calculated riskThe under-performing pharma company's foray into a competitive services business like diagnostics may seem counter-intuitive, as Lupin has ...
- Lupin to enter digital healthcare space in IndiaDrug major Lupin on Thursday said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platfo...
- Rakesh Jhunjhunwala’s third biggest stock bet not in the pink of healthInvestors looking for safer bets and craving for returns in an uncertain market are taking shelter in these defensive bets.
- Companies lend a hand to Covid-affected employeesITC’s suite of interventions include providing medical infrastructure such as Covid care facilities for those mildly symptomatic and oxygen...
- DigiHealth acquires Pharmarack and market research firm AIOCD AWACS for better IT infra playThe company looks to build the IT infrastructure and supply chain required for pharma distribution.
- India's top pharma majors in talks to buy PharmarackThe digital platform will provide the technological backbone to companies looking to build their own online B2B marketplace and, eventually...
- Lupin appoints Mark D McDade as independent directorMcDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, includ...
- In pharma, only the fittest will ride the crestThree leading pharma companies announced their June quarter results towards the end of the week — each with different levels of performance...
- Analysis: A tale of three pharma companies and a quarterCipla beat expectations riding the demand for Covid medication. The Street is likely to push the stock to its record high hit in 2015. Whil...
- Lupin launches first chatbot for patients to know about their ailmentsAs a start to digitize the patient journey in the overall healthcare space, Lupin is starting with ANYA to address queries related to diabe...
- Lupin to launch nearly 30 products in US market in FY18The drug firm is banking on the introduction of complex generics and biosimilars in the US to maintain its top five position in the market.
- Domestic drug market to grow by 13 per cent in 2013: ResearchThe 72,000-crore domestic drug market could grow between 11% and 13% in 2013, according to projections by pharma market research firms.
Load More
